Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database (Q5977801)

From MaRDI portal
Revision as of 16:49, 25 April 2024 by Import240425040427 (talk | contribs) (Added link to MaRDI item.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
scientific article

    Statements

    72
    0 references
    6
    0 references
    905-908
    0 references
    9 November 2011
    0 references
    0 references
    0 references
    0 references